Shine Medical Technologies entered into a three-way memorandum of understanding (MOU) with PT Industri Nuklir Indonesia (INUKI) and IPTN North America, Inc. (INA) last week that could potentially include an investment into Shine’s planned molybdenum-99 (moly-99)…
SUBSCRIBER ACCESS
Thank you for visiting
Weapons Complex Morning Briefing!
You must be logged in as a subscriber to view this page.
